NKGNNKGen Biotech Inc. Common Stock
0.0050USD0.00%Mkt Cap: 7.84M $P/E: —4d ago
NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. Th…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap7.84M $
Enterprise Value38.85M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-23.55M $
Revenue/Share—
Last Price0.0050 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.71
EV/Revenue—
P/S—
P/B-0.06
EPS (TTM)-1.33
EPS (Forward)—
52W Range
0.00101% of range0.3300
52W High0.3300 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-93.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.95M $
CapEx (TTM)48.00K $
FCF Margin—
FCF Yield-267.32%
Net Debt38.19M $
Net Debt/EBITDA-1.68
Balance Sheet
Debt/Equity-0.34
Current Ratio0.05
Quick Ratio0.00
Book Value/Sh-0.9810 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.130.60M
Float67.59M
Insiders58.97%
Institutions2.11%
Short Interest
Short Ratio0.4d
Short % Float5.53%
Short % Out.3.35%
Shares Short1.51M
Short (prev mo.)561.27K
Technical
SMA 500.0445 (-88.8%)
SMA 2000.0582 (-91.4%)
Beta0.72
S&P 52W Chg18.16%
Avg Vol (30d)7.89K
Avg Vol (10d)490
Technical Indicators
RSI (14)14.1
MACD-0.0138
MACD Signal-0.0138
MACD Hist.-0.0001
BB Upper0.0731 USD
BB Middle0.0222 USD
BB Lower-0.0286 USD
BB Width456.92%
ATR (14)0.0042 USD
Vol Ratio (20d)0.00x